From the Desk of Steve Strazza and Alfonso Depablos

Today’s most significant insider transaction report is another Form 4 filing by Warren Buffett’s Berkshire Hathaway $BRK.A.

Buffett continues to build his position in Occidental Petroleum $OXY, as he disclosed an additional purchase worth roughly $246 million.

We've adjusted a position in the Paid-to-Play portfolio today:

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Texas Capital Bancshares $TCBI director Robert Stallings.

Stallings reported a purchase of TCBI shares worth $436,320.

From the Desk of Ian Culley @IanCulley

Economists, columnists, and pundits are calling for an economic recession and even the possibility of deflation. 

Yet the US dollar is consolidating above a critical support zone.

Nothing bearish about that!

In fact, it’s standard price behavior within an ongoing uptrend. 

Sure, the pundits might be right. But both scenarios involve a swift decline in the US dollar.

And that’s simply not what’s happening today.   

In fact, forex markets are providing new opportunities to buy US dollars and sell other major currencies…

Check out the EUR/USD pair pulling back to a logical resistance level:

If you missed selling the breakdown in September, the market is giving you another shot.

The EUR/USD is...

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Texas Capital Bancshares $TCBI director Robert Stallings.

Stallings reported a purchase of TCBI shares worth $436,320.

We've adjusted a position in the Paid-to-Play portfolio today:

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Randall J. Weisenburger, independent director of Carnival Corporation & plc $CCL.

Weisenburger revealed an additional purchase of CCL shares worth a total of $1,150,000.

From the Desk of Steve Strazza @sstrazza and Alfonso Depablos @Alfcharts

This is one of our favorite bottom-up scans: Follow the Flow.

In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.

We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.

Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.

We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.

What remains is a list of stocks that large financial institutions are putting big money behind.

And they’re doing so for one reason only: because they think...

I'm making the bet here the Bond Bears may have overshot here. And today's trading action feels to me like $TLT put in an actionable level to lean against for risk management purposes.

This is not a bet that the final bottom is in for bonds. Only that odds favor a bounce that might have some legs.

With this caveat out of the way, here's how I'm going to play it.

From the Desk of Ian Culley @IanCulley

Gold and silver are pushing higher after posting potential failed breakdowns earlier this month.

If the October lows mark a critical inflection point – and it’s still a big “if” – the following three names will be ripping above our risk levels…

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Randall J. Weisenburger, independent director of Carnival Corporation & plc $CCL..

Weisenburger revealed an additional purchase of CCL shares worth a total of $1,150,000.

From the Desk of Steve Strazza @Sstrazza

Welcome to our latest Minor Leaguers report.

We've had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.

For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.

That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.

We expanded our universe to include some mid-caps.

To make the cut for our Minor Leaguers list now, a company must have a market cap between $1 and $4B.

And it doesn't have to be a Russell component — it can be any US-listed equity. With participation expanding around the globe, we want all those ADRs in our universe.

The same price and liquidity filters are applied. Then, as always, we sort by proximity to new highs in...

From the Desk of Kimmy Sokoloff

That was a nice snap back for the indices today.

It was good to see some green on the screen.

We've adjusted a position in the Paid-to-Play portfolio today:

Gold and silver are pushing higher after posting potential failed breakdowns earlier this month.

If the October lows mark a critical inflection point – and it’s still a big “if” – the following three names will be ripping above our risk levels…

First up is a $5B gold mining company headquartered in Toronto, Canada.

This is Alamos Gold $AGI:

AGI provided profits in the spring, launching it to “fan-favorite” status.

I like betting on past winners, bullish momentum, and strength. Alamos Gold checks all those boxes. 

I’m buying a break above 13, targeting 20 in the coming 3-6 months.

I also like buying strength in Kinross Gold $KGC, a $6.5B gold mining company also operating out of Toronto:

KGC recently posted a new 52-week high. Few gold mining stocks can tout comparable strength as many names sunk to fresh multi-year lows during the first week of October. 

The absolute and relative strength has my full attention.

I’m long KGC above 5.75, targeting 11.50 in the coming 4-6 months.

The third name isn’t as strong as the first two. But momentum is improving, and our risk is well-defined. If we’re...

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Len Blavatnik.

Blavatnik reported a purchase of $14.9 million in Day One Biopharmaceuticals $DAWN.